KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Free Cash Flow (2016 - 2025)

Amgen (AMGN) has 17 years of Free Cash Flow data on record, last reported at $961.0 million in Q4 2025.

  • For Q4 2025, Free Cash Flow fell 78.16% year-over-year to $961.0 million; the TTM value through Dec 2025 reached $8.1 billion, down 22.07%, while the annual FY2025 figure was $8.1 billion, 22.07% down from the prior year.
  • Free Cash Flow reached $961.0 million in Q4 2025 per AMGN's latest filing, down from $4.2 billion in the prior quarter.
  • Across five years, Free Cash Flow topped out at $4.4 billion in Q4 2024 and bottomed at $289.0 million in Q4 2023.
  • Average Free Cash Flow over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2021.
  • Peak YoY movement for Free Cash Flow: plummeted 87.48% in 2023, then skyrocketed 1422.49% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $2.5 billion in 2021, then decreased by 8.41% to $2.3 billion in 2022, then crashed by 87.48% to $289.0 million in 2023, then surged by 1422.49% to $4.4 billion in 2024, then crashed by 78.16% to $961.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $961.0 million in Q4 2025, $4.2 billion in Q3 2025, and $1.9 billion in Q2 2025.